78 related articles for article (PubMed ID: 21279704)
1. Preliminary results of a phase III randomized study comparing chemotherapy neoadjuvantly or concurrently with radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
Xu T; Hu C; Zhu G; He X; Wu Y; Ying H
Med Oncol; 2012 Mar; 29(1):272-8. PubMed ID: 21279704
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients with cervical nodal necrosis.
Lan M; Chen C; Huang Y; Tian L; Duan Z; Han F; Liao J; Deng M; Sio TT; Prayongrat A; Zheng L; Wu S; Lu T
Sci Rep; 2017 Feb; 7():42624. PubMed ID: 28211482
[TBL] [Abstract][Full Text] [Related]
3. Significant benefits of adding neoadjuvant chemotherapy before concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis of randomized controlled trials.
Wang M; Tian H; Li G; Ge T; Liu Y; Cui J; Han F
Oncotarget; 2016 Jul; 7(30):48375-48390. PubMed ID: 27356743
[TBL] [Abstract][Full Text] [Related]
4. Identification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone.
Chen YP; Zhang WN; Tang LL; Mao YP; Liu X; Chen L; Zhou GQ; Mai HQ; Shao JY; Jia WH; Kang TB; Zeng MS; Sun Y; Ma J
BMC Cancer; 2015 Nov; 15():930. PubMed ID: 26603423
[TBL] [Abstract][Full Text] [Related]
5. Comparison Long-term Outcome of Definitive Radiotherapy plus Different Chemotherapy Schedules in Patients with Advanced Nasopharyngeal Carcinoma.
Liu YC; Wang WY; Twu CW; Jiang RS; Liang KL; Lin PJ; Lin JW; Lin JC
Sci Rep; 2018 Jan; 8(1):470. PubMed ID: 29323141
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapy.
Du XJ; Tang LL; Chen L; Mao YP; Guo R; Liu X; Sun Y; Zeng MS; Kang TB; Shao JY; Lin AH; Ma J
Sci Rep; 2015 Nov; 5():16664. PubMed ID: 26564805
[TBL] [Abstract][Full Text] [Related]
7. Improving the efficacy and safety of concurrent chemoradiotherapy by neoadjuvant chemotherapy: a randomized controlled study of locally advanced cervical cancer with a large tumor.
Li F; Mei F; Yin S; Du Y; Hu L; Hong W; Li J
J Gynecol Oncol; 2024 Jan; 35(1):e10. PubMed ID: 37857565
[TBL] [Abstract][Full Text] [Related]
8. The long-term outcomes of alternating chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multiinstitutional phase II study.
Fuwa N; Kodaira T; Daimon T; Yoshizaki T
Cancer Med; 2015 Aug; 4(8):1186-95. PubMed ID: 25991077
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma.
Kim YI; Park JW; Kim BH; Woo SM; Kim TH; Koh YH; Lee WJ; Kim CM
Radiat Oncol; 2013 Dec; 8():292. PubMed ID: 24359879
[TBL] [Abstract][Full Text] [Related]
10. Significant survival benefit of adjuvant chemotherapy after concurrent chemoradiotherapy in locally advanced high-risk nasopharyngeal carcinoma.
Liang ZG; Chen XQ; Lin GX; Yu BB; Chen KH; Zhong QL; Nong SK; Li L; Qu S; Su F; Zhao W; Li Y; Zhu XD
Sci Rep; 2017 Feb; 7():41449. PubMed ID: 28150694
[TBL] [Abstract][Full Text] [Related]
11. Optimal cumulative dose of cisplatin for concurrent chemoradiotherapy among patients with non-metastatic nasopharyngeal carcinoma: a multicenter analysis in Thailand.
Ngamphaiboon N; Dechaphunkul A; Setakornnukul J; Dechaphunkul T; Jiratrachu R; Suktitipat B; Jiarpinitnun C; Pattaranutaporn P; Danchaivijitr P
BMC Cancer; 2020 Jun; 20(1):518. PubMed ID: 32493288
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival, toxicities, and the role of chrono-chemotherapy with different infusion rates in locally advanced nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy: a retrospective study with a 5-year follow-up.
Liu L; Luo X; Wu W; Li Y; Long J; Luo X; Chen X; Gong X; Zhao C; He Q; Li Z; Shang K; Chen Y; Xinyu X; Jin F
Front Oncol; 2024; 14():1371878. PubMed ID: 38585011
[TBL] [Abstract][Full Text] [Related]
13. Pre-chemoradiotherapy high platelet counts predict jaw osteoradionecrosis in locally advanced nasopharyngeal carcinoma patients.
Somay E; Topkan E; Kucuk A; Ozturk D; Ozkan EE; Ozdemir BS; Besen AA; Mertsoylu H; Pehlivan B; Selek U
J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101838. PubMed ID: 38518893
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of alternating chemoradiotherapy in patients with advanced nasopharyngeal cancer: a single-centre experience over the last decade.
Saijoh S; Matsuzuka T; Sato H; Suzuki M; Ikeda M; Suzuki R; Nakaegawa Y; Omori K
Acta Otorhinolaryngol Ital; 2018 Apr; 38(2):103-108. PubMed ID: 29967557
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of bevacizumab in neoadjuvant and concurrent chemoradiotherapy for refractory cervical cancer patients.
Yang H; Huang SG; Dong M; Wang X; He J; Su H; Liu C; Zhu Y; Wei L; Liu Z
Biomol Biomed; 2024 May; ():. PubMed ID: 38761408
[TBL] [Abstract][Full Text] [Related]
16. A Randomized Study to Evaluate Efficacy and Toxicity Profile of Paclitaxel-carboplatin as Neo-adjuvant Chemotherapy in Locally Advanced Supraglottic and Hypopharyngeal Primaries.
Vats P; Suhag V; Chakravarty N; Vashisth R; Jain M
Indian J Otolaryngol Head Neck Surg; 2023 Jun; 75(2):366-373. PubMed ID: 37275084
[TBL] [Abstract][Full Text] [Related]
17. Defining the Role of Neoadjuvant Chemotherapy Followed by Surgery in Locally Advanced Cancer Cervix: A Meta-analysis of Phase III Trials.
Osman MA
J Obstet Gynaecol India; 2016 Oct; 66(5):352-7. PubMed ID: 27486281
[TBL] [Abstract][Full Text] [Related]
18. Patterns of care for patients with nasopharyngeal carcinoma (KROG 11-06) in South Korea.
Sung SY; Kang MK; Kay CS; Keum KC; Kim SH; Kim YS; Kim WT; Kim JY; Kim JH; Moon SH; Ahn YC; Oh YT; Wu HG; Lee CG; Chung WK; Cho KH; Cho MJ; Choi JH
Radiat Oncol J; 2015 Sep; 33(3):188-97. PubMed ID: 26484302
[TBL] [Abstract][Full Text] [Related]
19. Weekly cetuximab concurrent with IMRT aggravated radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma: Results of a randomized phase II study.
Xu T; Liu Y; Dou S; Li F; Guan X; Zhu G
Oral Oncol; 2015 Sep; 51(9):875-9. PubMed ID: 26163437
[TBL] [Abstract][Full Text] [Related]
20. A phase III randomized study comparing neoadjuvant chemotherapy with concurrent chemotherapy combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma: updated long-term survival outcomes.
Xu T; Zhu G; He X; Ying H; Hu C
Oral Oncol; 2014 Feb; 50(2):71-6. PubMed ID: 24315404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
